世界のバイオ医薬品のためのシングルユース技術市場は、2025年に5706百万米ドルと算定されており、2026年には6214百万米ドルとなる見通しです。2026年から2032年の期間においては年平均成長率（CAGR）9.9%で推移し、2032年には10943百万米ドルに達すると予測されています。

本レポートは、バイオ医薬品のためのシングルユース技術メーカー、新規参入企業、および業界バリューチェーン全体の企業に対し、市場全体およびサブセグメント別の収益、生産量、平均価格に関する情報を、企業別、タイプ別、用途別、地域別に提供します。
世界のバイオ医薬品のためのシングルユース技術市場について、定量的・定性的分析を交えた包括的な概観を提供し、企業関係者が成長戦略の策定、競争環境の評価、現行市場における自社の位置付けの分析、バイオ医薬品のためのシングルユース技術に関する情報に基づいたビジネス判断を行うことを支援します。バイオ医薬品のためのシングルユース技術市場の規模、推定値及び予測値の観点から提示し、2025年を基準年として、2021年から2032年までの過去データ及び予測データを収録しております。

報告対象範囲
売上高・数量予測、企業シェア、競争環境、成長要因および市場トレンド

市場セグメンテーション
企業一覧
Danaher (US)
Sartorius (DE)
Thermo Fisher Scientific (US)
Merck KGaA (DE)
Repligen (US)
Meissner Filtration Products (US)
ABEC (US)
Avantor (US)
Corning (US)
Entegris (US)
Saint-Gobain Life Sciences (FR)
Watson-Marlow / BioPure (GB)
CPC / Colder Products (US)
Eppendorf (DE)
Getinge / Applikon (SE)
PBS Biotech (US)
Shanghai Tofflon Science and Technology Co., Ltd. (CN)
Shanghai LePure Biotech Co., Ltd. (CN)
Shanghai Duoning Biotechnology Co., Ltd. (CN)


タイプ別
Single-use Bioreactors
Single-use Bags & Containers
Filtration Assemblies
Tubing & Connectors
Others


用途別
Monoclonal Antibodies
Vaccines
Cell & Gene Therapy
Recombinant Proteins
Others


製品カテゴリー


市場セグメント
<50 L
50–500 L
500–1,000 L
>1,000 L

地域別
北米（アメリカ、カナダ、メキシコ）
欧州（ドイツ、フランス、イギリス、イタリアなど）
アジア太平洋（中国、日本、韓国、東南アジア、インドなど）
南米（ブラジルなど）
中東・アフリカ（トルコ、GCC諸国、アフリカなど）
本レポートは、世界のバイオ医薬品のためのシングルユース技術市場を包括的にセグメント化しております。地域別市場規模、タイプ別、用途別、企業別の市場規模も提供されます。より深い洞察を得るため、競争環境、主要競合他社、それぞれの市場順位をプロファイリングし、技術動向や新製品開発についても論じております。

本レポートの構成
第1章：バイオ医薬品のためのシングルユース技術の定義および調査範囲を明確化し、市場セグメント（タイプ別、用途別など）の概要を提示します。各セグメントの市場規模と将来の成長可能性を網羅し、現在の市場状況の概要を提供するとともに、短期・中期・長期の発展トレンドを分析します
第2章：バイオ医薬品のためのシングルユース技術メーカーの競争環境について、価格、生産量、価値ベースの市場シェア、最新の開発計画、合併・買収情報を含め詳細に分析します
第3章：バイオ医薬品のためのシングルユース技術の生産量／生産高および価値を地域・国別に検証し、今後6年間の各地域の市場規模と成長可能性について定量的な評価を提供します
第4章：地域および国レベルでのバイオ医薬品のためのシングルユース技術の消費動向を分析します。各地域および主要国における市場規模と成長可能性を定量化し、市場開発状況、見通し、対応可能な市場規模、国内生産量を概説します
第5章：バイオ医薬品のためのシングルユース技術に基づくタイプ別市場セグメントの構造を整理し、各セグメントの市場規模と成長ポテンシャルを明確化することで、企業・投資家によるブルーオーシャン機会の発見を支援します
第6章：用途別にバイオ医薬品のためのシングルユース技術の市場セグメントを整理し、各分野の市場規模、成長ポテンシャル、需要拡大余地を提示することで、下流市場における有望な参入機会や競争優位の確立に向けた判断材料を提供します
第7章：バイオ医薬品のためのシングルユース技術の主要プレイヤーを分析し、主要企業の基本情報（製品生産量／生産高、価値、価格、粗利益率、製品ポートフォリオ／新製品導入、最近の動向）を詳細に説明します
第8章：バイオ医薬品のためのシングルユース技術の上流および下流セグメントを含む業界バリューチェーンをレビューします
第9章：バイオ医薬品のためのシングルユース技術市場の動向と最新トレンドについて議論します。これには、メーカーにとっての推進要因、制約要因、課題、リスク、米国関税、関連政策分析が含まれます
第10章：主な調査結果と結論をまとめます
第11章：付録

The global Single-Use Technology for Biopharmaceuticals market was valued at US$ 5706 million in 2025 and is anticipated to reach US$ 10943 million by 2032, at a CAGR of 9.9% from 2026 to 2032.

Single-Use Technology for Biopharmaceuticals refers to disposable bioprocessing systems, components, and consumables used in the development and manufacturing of biopharmaceutical products. These technologies are designed to be used for a single production batch, process step, or manufacturing campaign and then discarded, replacing traditional stainless-steel systems that require cleaning, sterilization, and validation.

In the biopharmaceutical industry, single-use technology typically includes single-use bioreactors, media and buffer bags, storage bags, mixing systems, tubing assemblies, sterile connectors, filters, sampling systems, sensors, and fill-finish assemblies. These products are widely used in upstream processing, downstream processing, fluid management, formulation, and aseptic transfer for the production of monoclonal antibodies, vaccines, recombinant proteins, cell therapies, gene therapies, mRNA products, and other biologics.

The single-use technology for biopharmaceutical sector is characterized by high gross margins; leading international companies maintain gross margins exceeding 50% thanks to technological barriers and brand advantages.

Single-use technology in biopharmaceuticals is rapidly evolving toward greater intelligence, modularity, and sustainability. Future trends include "smart single-use systems"—integrating sensors and IoT technology—to enable real-time process monitoring and digital control; modular facility designs that shorten construction timelines and enhance production flexibility; and customized single-use solutions tailored for emerging therapies such as mRNA and cell and gene therapies. Regarding sustainability, the industry is shifting from traditional plastics to bio-based, biodegradable materials while simultaneously reducing waste through closed-loop recycling systems.

In terms of raw materials, multi-layer co-extruded films (e.g., polyethylene, EVOH barrier layers), silicone tubing, and thermoplastic elastomers (TPE) remain dominant; however, the supply chain is undergoing profound transformation. There is a heavy reliance on a limited number of European and American suppliers (such as Thermo Fisher, Sartorius, and Merck) for key resins and films, though geopolitical factors and the post-pandemic landscape are driving a diversification of global production capacity. Chinese enterprises are accelerating efforts to achieve import substitution for high-end films and precision connectors. Furthermore, increasingly stringent standards for extractables and leachables (E&L) are pushing raw materials toward higher purity, lower adsorption, and reduced particle shedding, with biocompatibility certifications (e.g., USP Class VI, ISO 10993) becoming essential market entry requirements.

This report delivers a comprehensive overview of the global Single-Use Technology for Biopharmaceuticals market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Single-Use Technology for Biopharmaceuticals. The Single-Use Technology for Biopharmaceuticals market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Single-Use Technology for Biopharmaceuticals market comprehensively. Regional market sizes by Type, by Application, by End User, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Single-Use Technology for Biopharmaceuticals manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation
By Company
Danaher (US)
Sartorius (DE)
Thermo Fisher Scientific (US)
Merck KGaA (DE)
Repligen (US)
Meissner Filtration Products (US)
ABEC (US)
Avantor (US)
Corning (US)
Entegris (US)
Saint-Gobain Life Sciences (FR)
Watson-Marlow / BioPure (GB)
CPC / Colder Products (US)
Eppendorf (DE)
Getinge / Applikon (SE)
PBS Biotech (US)
Shanghai Tofflon Science and Technology Co., Ltd. (CN)
Shanghai LePure Biotech Co., Ltd. (CN)
Shanghai Duoning Biotechnology Co., Ltd. (CN)

Segment by Type
Single-use Bioreactors
Single-use Bags & Containers
Filtration Assemblies
Tubing & Connectors
Others

Segment by End User
Biopharmaceutical Companies
CDMOs / CMOs
Research Institutes
Cell & Gene Therapy Companies
Vaccine Manufacturers

Segment by Scale of Operation
<50 L
50–500 L
500–1,000 L
>1,000 L

Segment by Application
Monoclonal Antibodies
Vaccines
Cell & Gene Therapy
Recombinant Proteins
Others

By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA

Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by End User, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Single-Use Technology for Biopharmaceuticals companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single-Use Technology for Biopharmaceuticals Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Single-use Bioreactors
1.2.3 Single-use Bags & Containers
1.2.4 Filtration Assemblies
1.2.5 Tubing & Connectors
1.2.6 Others
1.3 Market by End User
1.3.1 Global Single-Use Technology for Biopharmaceuticals Market Size Growth Rate by End User: 2021 vs 2025 vs 2032
1.3.2 Biopharmaceutical Companies
1.3.3 CDMOs / CMOs
1.3.4 Research Institutes
1.3.5 Cell & Gene Therapy Companies
1.3.6 Vaccine Manufacturers
1.4 Market by Scale of Operation
1.4.1 Global Single-Use Technology for Biopharmaceuticals Market Size Growth Rate by Scale of Operation: 2021 vs 2025 vs 2032
1.4.2 <50 L
1.4.3 50–500 L
1.4.4 500–1,000 L
1.4.5 >1,000 L
1.5 Market by Application
1.5.1 Global Single-Use Technology for Biopharmaceuticals Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Monoclonal Antibodies
1.5.3 Vaccines
1.5.4 Cell & Gene Therapy
1.5.5 Recombinant Proteins
1.5.6 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends
2.1 Global Single-Use Technology for Biopharmaceuticals Market Perspective (2021–2032)
2.2 Global Single-Use Technology for Biopharmaceuticals Growth Trends by Region
2.2.1 Global Single-Use Technology for Biopharmaceuticals Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Single-Use Technology for Biopharmaceuticals Historic Market Size by Region (2021–2026)
2.2.3 Single-Use Technology for Biopharmaceuticals Forecasted Market Size by Region (2027–2032)
2.3 Single-Use Technology for Biopharmaceuticals Market Dynamics
2.3.1 Single-Use Technology for Biopharmaceuticals Industry Trends
2.3.2 Single-Use Technology for Biopharmaceuticals Market Drivers
2.3.3 Single-Use Technology for Biopharmaceuticals Market Challenges
2.3.4 Single-Use Technology for Biopharmaceuticals Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Single-Use Technology for Biopharmaceuticals Players by Revenue
3.1.1 Global Top Single-Use Technology for Biopharmaceuticals Players by Revenue (2021–2026)
3.1.2 Global Single-Use Technology for Biopharmaceuticals Revenue Market Share by Players (2021–2026)
3.2 Global Top Single-Use Technology for Biopharmaceuticals Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Single-Use Technology for Biopharmaceuticals Revenue
3.4 Global Single-Use Technology for Biopharmaceuticals Market Concentration Ratio
3.4.1 Global Single-Use Technology for Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single-Use Technology for Biopharmaceuticals Revenue in 2025
3.5 Global Key Players of Single-Use Technology for Biopharmaceuticals Head Offices and Areas Served
3.6 Global Key Players of Single-Use Technology for Biopharmaceuticals, Products and Applications
3.7 Global Key Players of Single-Use Technology for Biopharmaceuticals, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans

4 Single-Use Technology for Biopharmaceuticals Breakdown Data by Type
4.1 Global Single-Use Technology for Biopharmaceuticals Historic Market Size by Type (2021–2026)
4.2 Global Single-Use Technology for Biopharmaceuticals Forecasted Market Size by Type (2027–2032)

5 Single-Use Technology for Biopharmaceuticals Breakdown Data by Application
5.1 Global Single-Use Technology for Biopharmaceuticals Historic Market Size by Application (2021–2026)
5.2 Global Single-Use Technology for Biopharmaceuticals Forecasted Market Size by Application (2027–2032)

6 North America
6.1 North America Single-Use Technology for Biopharmaceuticals Market Size (2021–2032)
6.2 North America Single-Use Technology for Biopharmaceuticals Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Single-Use Technology for Biopharmaceuticals Market Size by Country (2021–2026)
6.4 North America Single-Use Technology for Biopharmaceuticals Market Size by Country (2027–2032)
6.5 United States
6.6 Canada

7 Europe
7.1 Europe Single-Use Technology for Biopharmaceuticals Market Size (2021–2032)
7.2 Europe Single-Use Technology for Biopharmaceuticals Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Single-Use Technology for Biopharmaceuticals Market Size by Country (2021–2026)
7.4 Europe Single-Use Technology for Biopharmaceuticals Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland

8 Asia-Pacific
8.1 Asia-Pacific Single-Use Technology for Biopharmaceuticals Market Size (2021–2032)
8.2 Asia-Pacific Single-Use Technology for Biopharmaceuticals Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Single-Use Technology for Biopharmaceuticals Market Size by Region (2021–2026)
8.4 Asia-Pacific Single-Use Technology for Biopharmaceuticals Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand

9 Latin America
9.1 Latin America Single-Use Technology for Biopharmaceuticals Market Size (2021–2032)
9.2 Latin America Single-Use Technology for Biopharmaceuticals Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Single-Use Technology for Biopharmaceuticals Market Size by Country (2021–2026)
9.4 Latin America Single-Use Technology for Biopharmaceuticals Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size (2021–2032)
10.2 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size by Country (2021–2026)
10.4 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE

11 Key Players Profiles
11.1 Danaher (US)
11.1.1 Danaher (US) Company Details
11.1.2 Danaher (US) Business Overview
11.1.3 Danaher (US) Single-Use Technology for Biopharmaceuticals Introduction
11.1.4 Danaher (US) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.1.5 Danaher (US) Recent Development
11.2 Sartorius (DE)
11.2.1 Sartorius (DE) Company Details
11.2.2 Sartorius (DE) Business Overview
11.2.3 Sartorius (DE) Single-Use Technology for Biopharmaceuticals Introduction
11.2.4 Sartorius (DE) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.2.5 Sartorius (DE) Recent Development
11.3 Thermo Fisher Scientific (US)
11.3.1 Thermo Fisher Scientific (US) Company Details
11.3.2 Thermo Fisher Scientific (US) Business Overview
11.3.3 Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Introduction
11.3.4 Thermo Fisher Scientific (US) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.3.5 Thermo Fisher Scientific (US) Recent Development
11.4 Merck KGaA (DE)
11.4.1 Merck KGaA (DE) Company Details
11.4.2 Merck KGaA (DE) Business Overview
11.4.3 Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Introduction
11.4.4 Merck KGaA (DE) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.4.5 Merck KGaA (DE) Recent Development
11.5 Repligen (US)
11.5.1 Repligen (US) Company Details
11.5.2 Repligen (US) Business Overview
11.5.3 Repligen (US) Single-Use Technology for Biopharmaceuticals Introduction
11.5.4 Repligen (US) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.5.5 Repligen (US) Recent Development
11.6 Meissner Filtration Products (US)
11.6.1 Meissner Filtration Products (US) Company Details
11.6.2 Meissner Filtration Products (US) Business Overview
11.6.3 Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Introduction
11.6.4 Meissner Filtration Products (US) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.6.5 Meissner Filtration Products (US) Recent Development
11.7 ABEC (US)
11.7.1 ABEC (US) Company Details
11.7.2 ABEC (US) Business Overview
11.7.3 ABEC (US) Single-Use Technology for Biopharmaceuticals Introduction
11.7.4 ABEC (US) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.7.5 ABEC (US) Recent Development
11.8 Avantor (US)
11.8.1 Avantor (US) Company Details
11.8.2 Avantor (US) Business Overview
11.8.3 Avantor (US) Single-Use Technology for Biopharmaceuticals Introduction
11.8.4 Avantor (US) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.8.5 Avantor (US) Recent Development
11.9 Corning (US)
11.9.1 Corning (US) Company Details
11.9.2 Corning (US) Business Overview
11.9.3 Corning (US) Single-Use Technology for Biopharmaceuticals Introduction
11.9.4 Corning (US) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.9.5 Corning (US) Recent Development
11.10 Entegris (US)
11.10.1 Entegris (US) Company Details
11.10.2 Entegris (US) Business Overview
11.10.3 Entegris (US) Single-Use Technology for Biopharmaceuticals Introduction
11.10.4 Entegris (US) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.10.5 Entegris (US) Recent Development
11.11 Saint-Gobain Life Sciences (FR)
11.11.1 Saint-Gobain Life Sciences (FR) Company Details
11.11.2 Saint-Gobain Life Sciences (FR) Business Overview
11.11.3 Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Introduction
11.11.4 Saint-Gobain Life Sciences (FR) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.11.5 Saint-Gobain Life Sciences (FR) Recent Development
11.12 Watson-Marlow / BioPure (GB)
11.12.1 Watson-Marlow / BioPure (GB) Company Details
11.12.2 Watson-Marlow / BioPure (GB) Business Overview
11.12.3 Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Introduction
11.12.4 Watson-Marlow / BioPure (GB) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.12.5 Watson-Marlow / BioPure (GB) Recent Development
11.13 CPC / Colder Products (US)
11.13.1 CPC / Colder Products (US) Company Details
11.13.2 CPC / Colder Products (US) Business Overview
11.13.3 CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Introduction
11.13.4 CPC / Colder Products (US) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.13.5 CPC / Colder Products (US) Recent Development
11.14 Eppendorf (DE)
11.14.1 Eppendorf (DE) Company Details
11.14.2 Eppendorf (DE) Business Overview
11.14.3 Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Introduction
11.14.4 Eppendorf (DE) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.14.5 Eppendorf (DE) Recent Development
11.15 Getinge / Applikon (SE)
11.15.1 Getinge / Applikon (SE) Company Details
11.15.2 Getinge / Applikon (SE) Business Overview
11.15.3 Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Introduction
11.15.4 Getinge / Applikon (SE) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.15.5 Getinge / Applikon (SE) Recent Development
11.16 PBS Biotech (US)
11.16.1 PBS Biotech (US) Company Details
11.16.2 PBS Biotech (US) Business Overview
11.16.3 PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Introduction
11.16.4 PBS Biotech (US) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.16.5 PBS Biotech (US) Recent Development
11.17 Shanghai Tofflon Science and Technology Co., Ltd. (CN)
11.17.1 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Company Details
11.17.2 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Business Overview
11.17.3 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Introduction
11.17.4 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.17.5 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Recent Development
11.18 Shanghai LePure Biotech Co., Ltd. (CN)
11.18.1 Shanghai LePure Biotech Co., Ltd. (CN) Company Details
11.18.2 Shanghai LePure Biotech Co., Ltd. (CN) Business Overview
11.18.3 Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Introduction
11.18.4 Shanghai LePure Biotech Co., Ltd. (CN) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.18.5 Shanghai LePure Biotech Co., Ltd. (CN) Recent Development
11.19 Shanghai Duoning Biotechnology Co., Ltd. (CN)
11.19.1 Shanghai Duoning Biotechnology Co., Ltd. (CN) Company Details
11.19.2 Shanghai Duoning Biotechnology Co., Ltd. (CN) Business Overview
11.19.3 Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Introduction
11.19.4 Shanghai Duoning Biotechnology Co., Ltd. (CN) Revenue in Single-Use Technology for Biopharmaceuticals Business (2021–2026)
11.19.5 Shanghai Duoning Biotechnology Co., Ltd. (CN) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer